McKesson Corporation (MCK)

Cash ratio

Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020
Cash and cash equivalents US$ in thousands 4,583,000 4,678,000 3,532,000 6,278,000 4,015,000
Short-term investments US$ in thousands 240,000 237,000 346,000 269,000 170,000
Total current liabilities US$ in thousands 52,357,000 47,957,000 48,466,000 44,103,000 42,624,000
Cash ratio 0.09 0.10 0.08 0.15 0.10

March 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($4,583,000K + $240,000K) ÷ $52,357,000K
= 0.09

The cash ratio for McKesson Corporation has fluctuated over the past five years, ranging from 0.08 to 0.15. This ratio indicates the company's ability to cover its short-term liabilities with its cash and cash equivalents. A higher cash ratio suggests a greater ability to meet its short-term obligations without relying on external sources of funding.

Although the cash ratio decreased from 0.15 in 2021 to 0.09 in 2024, it remains relatively stable around the 0.10 mark. This may indicate that McKesson has maintained a healthy level of cash reserves compared to its current liabilities in recent years. However, a slight decline in the cash ratio in 2024 may warrant further investigation to understand the underlying reasons for the decrease and any potential implications for the company's liquidity position.


Peer comparison

Mar 31, 2024

Company name
Symbol
Cash ratio
McKesson Corporation
MCK
0.09
Cardinal Health Inc
CAH
0.15
Cencora Inc.
COR
0.05
Nu Skin Enterprises Inc
NUS
0.81

See also:

McKesson Corporation Cash Ratio